LEAD Horizon: How travelers in Austria gargle against the coro... - 27 September 2021 09:00

JOHANNESBURG, Sept. 27, 2021/PRNewswire-AsiaNet/-- Austrian success model with gold standard tests is possible worldwide Vienna got through the pandemic better in comparison to other European cities - thanks to a specially developed PCR test by the Austrian company LEAD Horizon, which is alrea...

  Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinica... - 24 September 2021 11:17

GAITHERSBURG, Md., Sept. 24, 2021 /PRNewswire-AsiaNet/ -- - Pivotal Phase 3 trial achieved all primary endpoints, demonstrating non-inferiority to a leading U.S.-licensed quadrivalent influenza vaccine - NanoFlu(TM) vaccine candidate induced significantly enhanced cell-mediated immune responses - N...

  Novavax and Serum Institute of India Announce Submission to Wo... - 24 September 2021 01:04

GAITHERSBURG, Md., Sept. 24, 2021 /PRNewswire-AsiaNet/ -- -- Novavax and Serum Institute of India file regulatory submission for World Health Organization Emergency Use Listing of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine Novavax, Inc. (Nasdaq: NVAX), a bio...

  Hainan Boao Lecheng International Medical Tourism Pilot Zone h... - 23 September 2021 22:16

BOAO, China, Sept. 23, 2021 /PRNewswire-Asianet/ -- - The event is co-organized by Winhealth Pharma The Hainan Boao Lecheng International Medical Tourism Pilot Zone ("Lecheng Pilot Zone")'s virtual promotional event to explain the favorable investment policies put in place for Japanese businesse...

  "Human Brains: Conversations", an online project dedicated to ... - 23 September 2021 20:00

MILAN, Sept. 23, 2021 /PRNewswire-AsiaNet/ -- Fondazione Prada presents the online project "Human Brains: Conversations," the second phase of the multidisciplinary program "Human Brains" dedicated to brain studies. "Conversations" will take place from September 2021 to April 2022 and will be ...

  MedAlliance announces completion of enrollment in Japanese SEL... - 23 September 2021 08:00

GENEVA, Sept. 23, 2021 /PRNewswire-AsiaNet/ -- MedAlliance, with its Japanese partner MDK Medical, has completed enrollment in the clinical study of its novel Sirolimus Drug Eluting Balloon (DEB), SELUTION SLR(TM), for the treatment of peripheral arterial disease (PAD). This follows the ac...

  INOVIO Receives Regulatory Authorization to Conduct Phase 3 Ef... - 22 September 2021 22:00

PLYMOUTH MEETING, Pa., Sept. 22, 2021 /PRNewswire-AsiaNet/ -- -- News follows recent regulatory authorizations to proceed with the trial in Brazil and the Philippines -- INOVIO and partner Advaccine are collaborating on the global Phase 3 trial in regions underserved by COVID-19 vaccines...

  pHOXBIO Announces Breakthrough Clinical Trial Results Concludi... - 22 September 2021 17:00

LONDON and NEW YORK, Sept. 22, 2021 /PRNewswire-AsiaNet/-- - pHOXWELL significantly reduced SARS-CoV-2 infection by 63% with tolerability comparable to placebo in high-risk population of healthcare workers - Novel self-administered nasal spray designed to augment existing preventive measures for SARS-CoV...

  LSO Medical Announces CE Approval of Next-Gen LUMESEAL Laser f... - 22 September 2021 01:15

LILLE, France, Sept. 21, 2021 /PRNewswire-AsiaNet/-- LUMESEAL(R) Adds SnakeBack(R) to Enhance Ease-of-Use and Control LSO MEDICAL SAS, international leader in vascular laser therapies, announced today the CE Approval of its newest generation EVLT SnakeBack(R) assisted system, the LUMESEAL(R) las...

  India Ministry of Health and Family Welfare Approves Exablate ... - 20 September 2021 13:30

HAIFA, Israel and MIAMI, Fla., Sept. 20, 2021 /PRNewswire-AsiaNet/ -- Insightec(R) [ http://www.insightec.com/ ] , a global healthcare company focused on transforming patient care, announced its incisionless neurosurgery platform, the Exablate(R) 4000, has received market approval by the Central Drugs Standard Contr...